# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 61-70 of 2566 results.
Evolution of the Therapeutic Care in Ovarian Cancer From 2011
Status: Recruiting
Last Changed: Feb 20, 2019
First Received: Sep 07, 2017
Disease(s): Ovarian Cancer
Locations: Institut de Cancérologie de l'Ouest - Paul Papin, Angers, France
Institut Bergonié, Bordeaux, France
Centre François Baclesse, Caen, France
Centre Jean Perrin, Clermont-ferrand, France
Centre Georges-François Leclerc, Dijon, France
... and 16 other locations.
Phase III Trial of Stage I Ovarian Cancer After Surgery
Status: Recruiting
Last Changed: Aug 30, 2019
First Received: Aug 21, 2019
Disease(s): Epithelial Ovarian Cancer
Intervention(s): adjuvant chemotherapy
Locations: Aichi Medical University Hospital, Nagakute-shi, Aichi, Japan
Tosei General Hospital, Seto-shi, Aichi, Japan
Fujita Health University Hospital, Toyoake-shi, Aichi, Japan
Hirosaki University School of Medicine & Hospital, Hirosaki-shi, Aomori, Japan
The Jikei University School of Medicine Kashiwa Hospital, Kashiwa-shi, Chiba, Japan
... and 99 other locations.
Cabazitaxel vs. Tocotrienol in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy.
Status: Completed
Last Changed: Sep 04, 2019
First Received: Sep 25, 2015
Disease(s): Ovarian Cancer
Intervention(s): Cabazitaxel, Tocotrienol
Locations: Vejle Hospital, Department of Oncology, Vejle, Denmark
Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer
Status: Completed
Last Changed: Mar 02, 2010
First Received: Dec 02, 2005
Disease(s): Ovarian Cancer
Intervention(s): Exemestane
Locations: Ottawa Regional Cancer Center, Ottawa, Ontario, Canada
Weekly Topotecan Therapy in Patients With Ovarian Cancer
Status: Terminated
Last Changed: Sep 13, 2006
First Received: Sep 19, 2005
Disease(s): Ovarian Cancer
Intervention(s): Topotecan
Locations: Weill Medcial College of Cornell University, New York, New York, United States
Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study
Status: Completed
Last Changed: Sep 12, 2018
First Received: Mar 05, 2012
Disease(s): Ovarian Cancer
Locations: University of Washington, Seattle, Washington, United States
Trial Comparing Niraparib-bevacizumab-TSR042 and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer
Status: Not yet recruiting
Last Changed: Jan 17, 2019
First Received: Jan 16, 2019
Disease(s): Ovarian Cancer
Intervention(s): Niraparib, Bevacizumab, TSR042, Carboplatin, Paclitaxel
Locations: NSGO, Copenhagen, Sjaelland, Denmark
Rigshospitalet, Copenhagen, Sjaelland, Denmark
Rigshospitalet, København Ø, Sjaelland, Denmark
Aalborg University Hospital, Aalborg, Denmark
Tampere University Hospital, Tampere, Finland
... and 4 other locations.
Role of Surgery in Advanced Ovarian Cancer
Status: Completed
Last Changed: Jun 10, 2019
First Received: Jun 10, 2019
Disease(s): Ovarian Cancer
Locations: Institut Claudius Regaud - IUCT-Oncopole, Toulouse, Occitanie, France
Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer
Status: Active, not recruiting
Last Changed: Jan 21, 2020
First Received: Sep 07, 2016
Disease(s): Recurrent Platinum Resistant Ovarian Cancer
Intervention(s): cediranib and olaparib
Locations: Research Site, Mobile, Alabama, United States
Research Site, Anchorage, Alaska, United States
Research Site, Downey, California, United States
Research Site, Greenbrae, California, United States
Research Site, Los Angeles, California, United States
... and 21 other locations.
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
Status: Completed
Last Changed: Mar 30, 2016
First Received: Sep 23, 2008
Disease(s): Ovarian Cancer
Intervention(s): Fourier transform ion cyclotron resonance mass spectrometry, chromatography, diagnostic laboratory biomarker analysis, questionnaire administration
Locations: Pine Street Foundation, San Anselmo, California, United States
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
California Pacific Medical Center - California Campus, San Francisco, California, United States
University of Maine, Orono, Maine, United States